New: Updates to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection

Updates to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection

The Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV (the Panel) has reviewed and updated the text and references of previous versions of the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection published on April 11, 2022, and October 11, 2022. Updates were made to the following sections:

• When to Start
• Clinical and Laboratory Monitoring of Pediatric HIV Infection
• What Not to Start: Regimens Not Recommended for Use Antiretroviral-Naive Children
• Special Considerations for Antiretroviral Therapy Use in Adolescents with HIV
• Adherence to Antiretroviral Therapy in Children and Adolescents with HIV
• Management of Medication Toxicity or Intolerance
• Management of Children Receiving Antiretroviral Therapy
• Appendix A: Pediatric Antiretroviral Drug Information

View the What’s New in the Pediatric Guidelines page for a summary of the changes